Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced Thursday it has filed clinical trial applications with the UK, German and Austrian regulatory agencies for IV rigosertib as a treatment in higher-risk myelodysplastic syndromes patients after failure of a hypomethylating agent therapy. Read More »

Portola Pharmaceuticals announced Thursday that the results of a preclinical study of andexanet alfa will be presented in a moderated poster session at the European Society of Cardiology 2015 Congress in London on Aug. 31 at 10:51 a.m. Read More »

The American College of Rheumatology's The Lupus Initiative (TLI) announced Tuesday the award of a one-year, $500,000 grant from the Office of Minority Health to expand its national education program. Read More »

Greatbatch, Inc. announced Thursday it has entered into a definitive agreement to acquire Lake Region Medical for around $1.73 billion in cash and stock. Read More »

TeaserPharmacy-based patient care solutions provider Ateb, Inc. recently launched its first-ever branding campaign, "Driving Healthy Outcomes for Patients, Pharmacies, and Payers."HeadlineAteb launches branding campaignBodyThe campaign's aim is to develop innovative patient engagement solutions. Read More »

Trial to test SGX942, a first-in-class innate defense regulator for use with head and neck cancers. Read More »

Gregory MacMichael and Howard B. Johnson named new vice presidents Read More »

Diamyd Medical announced Monday that it has entered into an exclusive license agreement for using the gluten protein gliadin for the treatment and prevention of type 1 diabetes. Read More »